This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Anal Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Carcinoma in Situ, Squamous Cell Carcinoma, Adenocarcinoma, Basal Cell Carcinoma, Melanoma, Others); Treatment Type (Chemotherapy, Surgery, Radiation Therapy, Immunotherapy); End User (Hospitals and Clinics, Research and Academic Institutes, Ambulatory Surgical Centers, Others) and Geography
Anal cancer is a rare type of malignancy that starts in the anus, which is the rectum's end. This type of cancer is usually associated with human papillomavirus (HPV), a sexually transmitted infection. It's prevalent in a majority of anal cancer cases. Some symptoms can might show bleeding from the anal area, lump or swelling near the anus or change in bowel habits, etc.
MARKET DYNAMICS
Factors such as the growing number of sexually transmitted diseases and rising prevalence of anal cancer are expected to drive market growth. Moreover, increasing research and development expenditure in oncology is also likely to boost the market growth. The high cost of anal cancer treatment and low awareness of this cancer act as major restraints for the market growth.
MARKET SCOPE
The "Anal Cancer Market Analysis to 2028" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of anal cancer market with detailed market segmentation with type, treatment type and end user. The anal cancer market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anal cancer market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The anal cancer market is segmented on the basis of type, treatment type and end user. On the basis of type, the anal cancer market is divided into carcinoma in situ, squamous cell carcinoma, adenocarcinoma, basal cell carcinoma, melanoma and others. On basis of treatment type, market can be segmented into chemotherapy, surgery, radiation therapy and immunotherapy. Based on end user, the anal cancer market can be segmented as hospitals and clinics, research and academic institutes, ambulatory surgical centres and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anal cancer market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anal cancer market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyses factors affecting anal cancer market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the anal cancer market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in anal cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anal cancer market are anticipated to have lucrative growth opportunities in the future with the rising demand for anal cancer in the global market. Below mentioned is the list of few companies engaged in the anal cancer market.
The report also includes the profiles of key players in anal cancer market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
Advaxis, Inc.
ORYX GmbH and Co. KG
Eli Lilly and Company
Genticel S.A
Merck and Co., Inc.
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Onconova Therapeutics Inc.
BioMimetix JV, LLC
Bayer AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Anal Cancer Market - By Type 1.3.2 Anal Cancer Market - By Treatment Type 1.3.3 Anal Cancer Market - By End User 1.3.4 Anal Cancer Market - By Region 1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANAL CANCER MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS
5. ANAL CANCER MARKET - KEY MARKET DYNAMICS 5.1. KEY MARKET DRIVERS 5.2. KEY MARKET RESTRAINTS 5.3. KEY MARKET OPPORTUNITIES 5.4. FUTURE TRENDS 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANAL CANCER MARKET - GLOBAL MARKET ANALYSIS 6.1. ANAL CANCER - GLOBAL MARKET OVERVIEW 6.2. ANAL CANCER - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE
7. ANAL CANCER MARKET - REVENUE AND FORECASTS TO 2028 - TYPE 7.1. OVERVIEW 7.2. TYPE MARKET FORECASTS AND ANALYSIS 7.3. CARCINOMA IN SITU 7.3.1. Overview 7.3.2. Carcinoma in Situ Market Forecast and Analysis 7.4. SQUAMOUS CELL CARCINOMA 7.4.1. Overview 7.4.2. Squamous Cell Carcinoma Market Forecast and Analysis 7.5. ADENOCARCINOMA 7.5.1. Overview 7.5.2. Adenocarcinoma Market Forecast and Analysis 7.6. BASAL CELL CARCINOMA 7.6.1. Overview 7.6.2. Basal Cell Carcinoma Market Forecast and Analysis 7.7. MELANOMA 7.7.1. Overview 7.7.2. Melanoma Market Forecast and Analysis 7.8. OTHERS 7.8.1. Overview 7.8.2. Others Market Forecast and Analysis 8. ANAL CANCER MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE 8.1. OVERVIEW 8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS 8.3. CHEMOTHERAPY 8.3.1. Overview 8.3.2. Chemotherapy Market Forecast and Analysis 8.4. SURGERY 8.4.1. Overview 8.4.2. Surgery Market Forecast and Analysis 8.5. RADIATION THERAPY 8.5.1. Overview 8.5.2. Radiation Therapy Market Forecast and Analysis 8.6. IMMUNOTHERAPY 8.6.1. Overview 8.6.2. Immunotherapy Market Forecast and Analysis 9. ANAL CANCER MARKET - REVENUE AND FORECASTS TO 2028 - END USER 9.1. OVERVIEW 9.2. END USER MARKET FORECASTS AND ANALYSIS 9.3. HOSPITALS AND CLINICS 9.3.1. Overview 9.3.2. Hospitals and Clinics Market Forecast and Analysis 9.4. RESEARCH AND ACADEMIC INSTITUTES 9.4.1. Overview 9.4.2. Research and Academic Institutes Market Forecast and Analysis 9.5. AMBULATORY SURGICAL CENTERS 9.5.1. Overview 9.5.2. Ambulatory Surgical Centers Market Forecast and Analysis 9.6. OTHERS 9.6.1. Overview 9.6.2. Others Market Forecast and Analysis
10. ANAL CANCER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 10.1. NORTH AMERICA 10.1.1 North America Anal Cancer Market Overview 10.1.2 North America Anal Cancer Market Forecasts and Analysis 10.1.3 North America Anal Cancer Market Forecasts and Analysis - By Type 10.1.4 North America Anal Cancer Market Forecasts and Analysis - By Treatment Type 10.1.5 North America Anal Cancer Market Forecasts and Analysis - By End User 10.1.6 North America Anal Cancer Market Forecasts and Analysis - By Countries 10.1.6.1 United States Anal Cancer Market 10.1.6.1.1 United States Anal Cancer Market by Type 10.1.6.1.2 United States Anal Cancer Market by Treatment Type 10.1.6.1.3 United States Anal Cancer Market by End User 10.1.6.2 Canada Anal Cancer Market 10.1.6.2.1 Canada Anal Cancer Market by Type 10.1.6.2.2 Canada Anal Cancer Market by Treatment Type 10.1.6.2.3 Canada Anal Cancer Market by End User 10.1.6.3 Mexico Anal Cancer Market 10.1.6.3.1 Mexico Anal Cancer Market by Type 10.1.6.3.2 Mexico Anal Cancer Market by Treatment Type 10.1.6.3.3 Mexico Anal Cancer Market by End User 10.2. EUROPE 10.2.1 Europe Anal Cancer Market Overview 10.2.2 Europe Anal Cancer Market Forecasts and Analysis 10.2.3 Europe Anal Cancer Market Forecasts and Analysis - By Type 10.2.4 Europe Anal Cancer Market Forecasts and Analysis - By Treatment Type 10.2.5 Europe Anal Cancer Market Forecasts and Analysis - By End User 10.2.6 Europe Anal Cancer Market Forecasts and Analysis - By Countries 10.2.6.1 Germany Anal Cancer Market 10.2.6.1.1 Germany Anal Cancer Market by Type 10.2.6.1.2 Germany Anal Cancer Market by Treatment Type 10.2.6.1.3 Germany Anal Cancer Market by End User 10.2.6.2 France Anal Cancer Market 10.2.6.2.1 France Anal Cancer Market by Type 10.2.6.2.2 France Anal Cancer Market by Treatment Type 10.2.6.2.3 France Anal Cancer Market by End User 10.2.6.3 Italy Anal Cancer Market 10.2.6.3.1 Italy Anal Cancer Market by Type 10.2.6.3.2 Italy Anal Cancer Market by Treatment Type 10.2.6.3.3 Italy Anal Cancer Market by End User 10.2.6.4 Spain Anal Cancer Market 10.2.6.4.1 Spain Anal Cancer Market by Type 10.2.6.4.2 Spain Anal Cancer Market by Treatment Type 10.2.6.4.3 Spain Anal Cancer Market by End User 10.2.6.5 United Kingdom Anal Cancer Market 10.2.6.5.1 United Kingdom Anal Cancer Market by Type 10.2.6.5.2 United Kingdom Anal Cancer Market by Treatment Type 10.2.6.5.3 United Kingdom Anal Cancer Market by End User 10.2.6.6 Rest of Europe Anal Cancer Market 10.2.6.6.1 Rest of Europe Anal Cancer Market by Type 10.2.6.6.2 Rest of Europe Anal Cancer Market by Treatment Type 10.2.6.6.3 Rest of Europe Anal Cancer Market by End User 10.3. ASIA-PACIFIC 10.3.1 Asia-Pacific Anal Cancer Market Overview 10.3.2 Asia-Pacific Anal Cancer Market Forecasts and Analysis 10.3.3 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By Type 10.3.4 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By Treatment Type 10.3.5 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By End User 10.3.6 Asia-Pacific Anal Cancer Market Forecasts and Analysis - By Countries 10.3.6.1 Australia Anal Cancer Market 10.3.6.1.1 Australia Anal Cancer Market by Type 10.3.6.1.2 Australia Anal Cancer Market by Treatment Type 10.3.6.1.3 Australia Anal Cancer Market by End User 10.3.6.2 China Anal Cancer Market 10.3.6.2.1 China Anal Cancer Market by Type 10.3.6.2.2 China Anal Cancer Market by Treatment Type 10.3.6.2.3 China Anal Cancer Market by End User 10.3.6.3 India Anal Cancer Market 10.3.6.3.1 India Anal Cancer Market by Type 10.3.6.3.2 India Anal Cancer Market by Treatment Type 10.3.6.3.3 India Anal Cancer Market by End User 10.3.6.4 Japan Anal Cancer Market 10.3.6.4.1 Japan Anal Cancer Market by Type 10.3.6.4.2 Japan Anal Cancer Market by Treatment Type 10.3.6.4.3 Japan Anal Cancer Market by End User 10.3.6.5 South Korea Anal Cancer Market 10.3.6.5.1 South Korea Anal Cancer Market by Type 10.3.6.5.2 South Korea Anal Cancer Market by Treatment Type 10.3.6.5.3 South Korea Anal Cancer Market by End User 10.3.6.6 Rest of Asia-Pacific Anal Cancer Market 10.3.6.6.1 Rest of Asia-Pacific Anal Cancer Market by Type 10.3.6.6.2 Rest of Asia-Pacific Anal Cancer Market by Treatment Type 10.3.6.6.3 Rest of Asia-Pacific Anal Cancer Market by End User 10.4. MIDDLE EAST AND AFRICA 10.4.1 Middle East and Africa Anal Cancer Market Overview 10.4.2 Middle East and Africa Anal Cancer Market Forecasts and Analysis 10.4.3 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By Type 10.4.4 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By Treatment Type 10.4.5 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By End User 10.4.6 Middle East and Africa Anal Cancer Market Forecasts and Analysis - By Countries 10.4.6.1 South Africa Anal Cancer Market 10.4.6.1.1 South Africa Anal Cancer Market by Type 10.4.6.1.2 South Africa Anal Cancer Market by Treatment Type 10.4.6.1.3 South Africa Anal Cancer Market by End User 10.4.6.2 Saudi Arabia Anal Cancer Market 10.4.6.2.1 Saudi Arabia Anal Cancer Market by Type 10.4.6.2.2 Saudi Arabia Anal Cancer Market by Treatment Type 10.4.6.2.3 Saudi Arabia Anal Cancer Market by End User 10.4.6.3 U.A.E Anal Cancer Market 10.4.6.3.1 U.A.E Anal Cancer Market by Type 10.4.6.3.2 U.A.E Anal Cancer Market by Treatment Type 10.4.6.3.3 U.A.E Anal Cancer Market by End User 10.4.6.4 Rest of Middle East and Africa Anal Cancer Market 10.4.6.4.1 Rest of Middle East and Africa Anal Cancer Market by Type 10.4.6.4.2 Rest of Middle East and Africa Anal Cancer Market by Treatment Type 10.4.6.4.3 Rest of Middle East and Africa Anal Cancer Market by End User 10.5. SOUTH AND CENTRAL AMERICA 10.5.1 South and Central America Anal Cancer Market Overview 10.5.2 South and Central America Anal Cancer Market Forecasts and Analysis 10.5.3 South and Central America Anal Cancer Market Forecasts and Analysis - By Type 10.5.4 South and Central America Anal Cancer Market Forecasts and Analysis - By Treatment Type 10.5.5 South and Central America Anal Cancer Market Forecasts and Analysis - By End User 10.5.6 South and Central America Anal Cancer Market Forecasts and Analysis - By Countries 10.5.6.1 Brazil Anal Cancer Market 10.5.6.1.1 Brazil Anal Cancer Market by Type 10.5.6.1.2 Brazil Anal Cancer Market by Treatment Type 10.5.6.1.3 Brazil Anal Cancer Market by End User 10.5.6.2 Argentina Anal Cancer Market 10.5.6.2.1 Argentina Anal Cancer Market by Type 10.5.6.2.2 Argentina Anal Cancer Market by Treatment Type 10.5.6.2.3 Argentina Anal Cancer Market by End User 10.5.6.3 Rest of South and Central America Anal Cancer Market 10.5.6.3.1 Rest of South and Central America Anal Cancer Market by Type 10.5.6.3.2 Rest of South and Central America Anal Cancer Market by Treatment Type 10.5.6.3.3 Rest of South and Central America Anal Cancer Market by End User
11. INDUSTRY LANDSCAPE 11.1. MERGERS AND ACQUISITIONS 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 11.3. NEW PRODUCT LAUNCHES 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANAL CANCER MARKET, KEY COMPANY PROFILES 12.1. ADVAXIS, INC. 12.1.1. Key Facts 12.1.2. Business Description 12.1.3. Products and Services 12.1.4. Financial Overview 12.1.5. SWOT Analysis 12.1.6. Key Developments 12.2. ORYX GMBH AND CO. KG 12.2.1. Key Facts 12.2.2. Business Description 12.2.3. Products and Services 12.2.4. Financial Overview 12.2.5. SWOT Analysis 12.2.6. Key Developments 12.3. ELI LILLY AND COMPANY 12.3.1. Key Facts 12.3.2. Business Description 12.3.3. Products and Services 12.3.4. Financial Overview 12.3.5. SWOT Analysis 12.3.6. Key Developments 12.4. GENTICEL S.A 12.4.1. Key Facts 12.4.2. Business Description 12.4.3. Products and Services 12.4.4. Financial Overview 12.4.5. SWOT Analysis 12.4.6. Key Developments 12.5. MERCK AND CO., INC. 12.5.1. Key Facts 12.5.2. Business Description 12.5.3. Products and Services 12.5.4. Financial Overview 12.5.5. SWOT Analysis 12.5.6. Key Developments 12.6. F. HOFFMANN-LA ROCHE LTD 12.6.1. Key Facts 12.6.2. Business Description 12.6.3. Products and Services 12.6.4. Financial Overview 12.6.5. SWOT Analysis 12.6.6. Key Developments 12.7. GLAXOSMITHKLINE PLC 12.7.1. Key Facts 12.7.2. Business Description 12.7.3. Products and Services 12.7.4. Financial Overview 12.7.5. SWOT Analysis 12.7.6. Key Developments 12.8. ONCONOVA THERAPEUTICS INC. 12.8.1. Key Facts 12.8.2. Business Description 12.8.3. Products and Services 12.8.4. Financial Overview 12.8.5. SWOT Analysis 12.8.6. Key Developments 12.9. BIOMIMETIXJV, LLC 12.9.1. Key Facts 12.9.2. Business Description 12.9.3. Products and Services 12.9.4. Financial Overview 12.9.5. SWOT Analysis 12.9.6. Key Developments 12.10. BAYER AG 12.10.1. Key Facts 12.10.2. Business Description 12.10.3. Products and Services 12.10.4. Financial Overview 12.10.5. SWOT Analysis 12.10.6. Key Developments
13. APPENDIX 13.1. ABOUT THE INSIGHT PARTNERS 13.2. GLOSSARY OF TERMS
